Meet the Minds Behind ExaVeyra Sciences
ExaVeyra Sciences was founded by an M.Sc. organic chemist and former nucleotide process chemist in next-generation DNA sequencing. Every product in our catalog is verified through the same analytical rigor applied in the laboratory, including purity analysis, stability assessment, and spectroscopic validation.
Our Mission
To democratize access to regenerative medicine by providing healthcare professionals with premium, research-backed products and the education needed to deliver exceptional patient care. We bridge the gap between laboratory innovation and clinical application, making the supply chain transparent, compliant, and chemist-verified.
Our Vision
A supply chain where every clinic, whatever its size, can see the same documentation the largest institutions see.
Our People
Meet the team driving innovation in regenerative medicine supply.
Benn Bluestein-Veyra, M.Sc.
Founder & CEO
- M.Sc. Organic Chemistry, Universidad Autónoma de Madrid (2019)
- Thesis: Cobalt-catalyzed C-H functionalization of N-benzylpicolinamide with aliphatic 1,3-diynes
- Former Nucleotide Process Organic Chemist, Next-Generation DNA Sequencing
- Analytical Chemist: Stability Studies, Dye-Conjugated DNA Nucleotides
Conducting the chemical reactions that I could imagine in 3D space into reality in the laboratory made me deeply respect the power of molecules to influence our existence on this planet. An ACL reconstruction is what first drew me into reading the peptide and biologics literature, and the chemistry behind it is what led me to build a supplier that reads the documentation before it reads the brochure. ExaVeyra Sciences bridges the gap between laboratory innovation and clinical application. I received my M.Sc. in organic chemistry from la Universidad Autónoma de Madrid in 2019 with my master's thesis "Cobalt-catalyzed C-H functionalization of N-benzylpicolinamide with aliphatic 1,3-diynes." I also spent three years in the field of next-generation DNA sequencing, working as a nucleotide process organic chemist and analytical chemist. I ran stability studies of dye-conjugated DNA nucleotides. From understanding the nature of purity analysis, stability studies, and various spectroscopic and spectrophotometric techniques, I founded this company to enable clinics to access robust chemical and biological supply chains.
These statements reflect personal experience and scientific interest only. They are not intended to diagnose, treat, cure, or prevent any disease. Exosome material is supplied for topical aesthetic use and laboratory research. Compounded preparations are dispensed by our 503A pharmacy partner on a patient-specific prescription.
Dr. Janine Hopkins, MD, FAAD
Dermatology & Regenerative Medicine
Founder & Medical Director, HopkinsDermatology · CEO, Trinnovations, Inc.
- Board-Certified Dermatologist · FAAD · AAD · ASDS · Women's Dermatologic Society
- Inventor: CuraCator™ (sterile single-use biologic applicator) and CuraStick™
- Co-author, peer-reviewed publications in Oncology and Therapy (IGSRT for non-melanoma skin cancer)
- Clinical partner, SkinCure Oncology · Image-Guided Superficial Radiation Therapy
- Scientific poster presenter, Women's Dermatologic Society and LSU Health New Orleans School of Medicine
- Key Opinion Leader and clinical advisor to multiple medical and aesthetic companies
Dr. Janine Hopkins, MD, FAAD is a board-certified dermatologist, entrepreneur, and medical device innovator with more than 30 years of clinical experience. She is the founder and medical director of Hopkins Dermatology and the founder and CEO of Trinnovations, Inc., where she focuses on advancing application science and regenerative treatment delivery.
Dr. Hopkins is the inventor of CuraCator™ and CuraStick™ and is a national and international speaker on regenerative medicine, aesthetic procedures, and laser science. She serves as a clinical advisor and key opinion leader to multiple medical and aesthetic companies and is actively involved in clinical research, scientific publications, and physician education.
Areas of advisory focus
Biologic & topical delivery systems
Regenerative medicine protocols
Clinical device evaluation
Practitioner education & adoption
PRP application & wound healing
Imaging-guided skin cancer therapy
How We Vet Every Product Before It Reaches Your Clinic
Regenerative medicine sourcing requires more than a vendor relationship. Each product in the ExaVeyra catalog is evaluated against the same analytical standards applied in pharmaceutical and biotech manufacturing, because the founder built a career on them.
cGMP Manufacturing Verification
Every exosome lot originates from the manufacturer named on the product page, with cGMP documentation available on request.
Particle Characterization & NTA Analysis
MSC-derived exosome lots are evaluated for particle size distribution and concentration data via Nanoparticle Tracking Analysis. We look for consistent size profiles (typically 30 to 150 nm) and documented particle-to-protein ratios.
Certificate of Analysis Review
Every COA is read for what it actually says, not just that it exists. Impurity profiles, identity markers, potency assays, and stability data are reviewed with the same rigor applied in analytical chemistry lab settings.
Endotoxin & Sterility Standards
Exosome lots carry a certificate of analysis, and the manufacturer is named on every product page so its registration can be checked.
Cold-Chain & Logistics Compliance
Liquid exosome formulations and other temperature-sensitive biologics ship with validated cold-chain packaging. We confirm products maintain efficacy specifications across transit conditions before adding them to the catalog.
Peptide & Compounding Source Verification
Compounded preparations are dispensed by our 503A pharmacy partner, licensed by its state Board of Pharmacy, on a patient-specific prescription. ExaVeyra does not work with a 503B outsourcing facility.
Our Values
The principles that guide everything we do.
Science-First Approach
Every product we list carries supplier documentation we have read.
Uncompromising Quality
Complete lot traceability, with a certificate of analysis available on request for every exosome lot.
Practitioner-Centered Support
Our mission is to support licensed clinicians with rigorously sourced, verified biologics for practitioner-designed protocols.
Partner Success
We grow when our partner clinics succeed. Your success is our priority.
Ready to Partner With Us?
Join our network of healthcare professionals advancing regenerative medicine, backed by a supply chain built by a chemist, for clinicians.